This analysis evaluates dosage optimization in cancer treatments using radiopharmaceutical therapies, suggesting improved outcomes.
There has been a surge in the use of radiopharmaceutical therapies (RPTs) to treat cancer in recent years. As these technologies develop, the use of dosimetry to quantify absorbed dose to normal organs and tumors offers the opportunity to optimize dosage (administered activity and schedule) and
No takes yet. Share an insight, caveat, or question.
Kiess et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: